ingenza

Ingenza is a technology-driven contract research, development, and manufacturing organization (CRDMO) established in 2003 and based in Edinburgh. The company specializes in engineering biology, utilizing its proprietary inGenius® platform—which includes technologies like codABLE™—to address manufacturing challenges in complex biologics, small molecule pharmaceuticals, and sustainable industrial products. Ingenza’s services span molecular genetics, microbial strain and mammalian cell-line engineering, protein production, biocatalysis, and bioprocess development, supported by an integrated 13,500 sq ft facility that combines molecular biology, fermentation, and analytical chemistry.

The company partners with clients across diverse sectors, including pharmaceuticals, agrobiotechnology, animal health, and industrial chemicals, to de-risk and streamline the development of novel molecules. By delivering scalable, ICH-compliant processes and tailored manufacturing solutions, Ingenza helps customers meet regulatory requirements and reach commercial milestones more efficiently. Their work has resulted in significant yield enhancements and successful production outcomes for numerous customer targets, enabling partners to achieve their Net Zero objectives and improve the competitiveness of their bio-based manufacturing initiatives.